AnteoTech can make millions of rapid antigen tests but yet to gain approval by ...
Australian company that can make MILLIONS of rapid antigen tests a year is tied up in red tape while the country cries out for an alternative to hours-long PCR queues Brisbane-based biotechnology company AnteoTech is producing rapid tests Anteotech already distributes the 15-minute tests around USA and Europe But they are yet to gain approval from the Therapeutic Goods Administration The company's chief executive Derek Thomson says red tape is 'frustrating'
View
comments
An Australian company that can produce millions of Covid-19 rapid antigen tests can do nothing to help the country's testing crisis due to red tape.
Brisbane biotechnology company AnteoTech3 has developed its own 15-minute test that is already regularly used in the US and Europe.
But the Therapeutic Goods Administration is yet to give the company the green light to sell its kits in Australia.
Wait times for Covid-19 tests have skyrocketed amid a surge in Covid cases in recent weeks (pictured in Sydney)
With thousands of Australians queueing up all day to get a PCR test, only to then wait up to another five days for results, chief executive Derek Thomson said the red tape was adding to the delays.
'We've always said
